Olaparib in Metastatic Breast Cancer: The Impact of Prior Cyclin-Dependent Kinase 4 and 6 Inhibitor Exposure on Efficacy. Yan J, Xiong W, Cai H. J Clin Oncol 2026 Jul 7:JCO2600539. doi: 10.1200/JCO-26-00539.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yan J, Xiong W, Cai H. Olaparib in Metastatic Breast Cancer: The Impact of Prior Cyclin-Dependent Kinase 4 and 6 Inhibitor Exposure on Efficacy. J Clin Oncol 2026 Jul 7:JCO2600539. doi: 10.1200/JCO-26-00539.
PMID: 42413060